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Areas of secondary hyperalgesia can be assessed using quantitative sensory testing (QST). 
Delivering noxious electrocutaneous stimulation could provide added benefit by allowing 
multiple measurements of the magnitude of hyperalgesia. We aimed to characterise the use 
of electrical pain perception (EPP) thresholds alongside QST as a means by which to measure 
changes in pain thresholds within an area of secondary mechanical hyperalgesia.  
Methods 
EPP and heat pain thresholds (HPT) were measured at 5 distinct points at baseline and 
following 1% capsaicin cream application; 1 within a central zone and 4 within a secondary 
zone. Areas of mechanical secondary mechanical hyperalgesia were mapped using QST. In a 
further 14 participants, capsaicin-induced reduction in EPP thresholds was mapped using a 
radial lines approach across 24 points.  
Results 
There was a reduction in EPP threshold measured at the 4 points within the secondary zone 
which was within the mapped area of mechanical secondary hyperalgesia. The magnitude of 
secondary hyperalgesia could be split into a mild (~4% reduction) and severe (~21% reduction) 
area within an individual subject. There was no reduction in HPT within the secondary zone but 
there was a reduction in both HPT and EPP threshold within the primary zone. EPP mapping 







Measuring capsaicin-induced reduction in EPP thresholds can be used to map hyperalgesic 
areas in humans. This semi-automated approach allows rapid assessment of the magnitude of 
hyperalgesia, both within an individual subject and across a study population.    





























Chronic pain affects up to 28 million people in the UK and is associated with a low quality of 
life and poor pain control with conventional use of analgesics (1, 2). Understanding the 
mechanisms of chronic pain is imperative in the development of more effective personalised 
therapies (3). A common feature of chronic pain is the development of secondary hyperalgesia 
which is a spinally-mediated enhanced pain response in an area adjacent to the initial injury 
site (4, 5). Quantitative sensory testing (QST) techniques used in human surrogate pain models 
can be used to assess experimentally-induced secondary hyperalgesia have been key to 
furthering our understanding of the mechanisms of chronic pain (6). However, it is possible 
that adding further assessment methods to current QST-based approaches has the potential 
to provide new insight into the secondary hyperalgesia response.  
The capsaicin model has been routinely used to investigate the mechanisms of secondary 
hyperalgesia (7-14). QST is used both clinically and experimentally to map the area of 
hyperalgesia using a radial lines approach, which manifests as selective changes in the function 
of mechanically sensitive Aδ-fibre afferents (7, 10, 14-16). As well as measuring the surface 
area on the skin affected by secondary hyperalgesia, it also imperative that the magnitude of 
static secondary hyperalgesia is also assessed at specific points within the affected area in 
order to achieve more detailed information. It is possible to do this by measuring changes in 
the mechanical pain threshold or stimulus-response functions (17); however this can be time 
consuming if more than one site is to be assessed within an area of secondary hyperalgesia.  
The use of a computer controlled electrical stimulus has been shown to be a reliable method 
to assess cutaneous sensitivity (18) and has been used to measure changes in pain threshold 





noxious stimuli with rapid onset and offset times it is possible to quickly measure electrical pain 
perception (EPP) thresholds using the methods of limits approach by increasing or decreasing 
the current intensity (21). Short square-wave electrical stimulation will directly excite the full 
spectrum of peripheral nerve fibres and therefore this approach cannot be readily used to 
assess specific nerve fibre function (22). However, it is possible that measuring EPP thresholds 
could be used alongside traditional QST methods to provide a detailed overview of the changes 
in magnitude of pain thresholds within a secondary hyperalgesia area associated with altered 
mechanical pain sensitivity.  
The aim of this study was to first characterise the use of EPP as a means by which to capture 
capsaicin-induced changes in pain threshold across four different points within a mapped area 
of secondary mechanical hyperalgesia. It was anticipated that there would be within-subject 
differences in the degree of change in EPP threshold within the mapped surface area of 
mechanical hyperalgesia. In a follow-on study we aimed to map the changes in EPP threshold 
using a radial lines approach with a view to provide a more detailed overview of changes in 
pain thresholds measured across multiple points within an area of secondary hyperalgesia. 
Methods  
Subject screening and recruitment   
All procedures were approved by the local research ethics committee. We recruited 26 healthy 
participants across 2 studies (study 1: n = 12; mean (SD) age 20.8 ± 3.1; 3 females; study 2: n = 
14; mean age 24.7 ± 10.1; 5 females). All participants were informed of the experimental 
protocols and subsequently provided written consent in accordance with the principles of the 
declaration of Helsinki. All participants were initially screened to see if they met any of the 





conditions, immune-suppression, inflammatory disease, psychiatric conditions, taking steroid, 
antibiotic or pain medicines).  
Capsaicin pain model 
All Participants received topical application of capsaicin cream (1% w/w, Pharmacierge, 
London, UK). Using a 1 ml syringe, 50 µl was ejected onto a 9 mm diameter clear plastic disc 
which was then placed face-down on the skin, remaining in place for the remainder of the 
protocol (area of capsaicin skin contact: 64 mm2) (16). The participants used a modified VAS 
used previously (16) where 0 = no sensation; 50 = pain threshold; 100 = worst pain imaginable. 
Following application of capsaicin cream, the participants were instructed to rate the sensation 
every 3 minutes for 120 minutes. The participants described the sensation initially as ‘’tingling’’ 
which increased in intensity over approximately 45 minutes until a distinct ‘’stinging’’ or 
‘’burning’’ pain was perceived (i.e. 50 VAS rating).  
Mapping secondary mechanical hyperalgesia   
The location of capsaicin cream application was standardised by measuring an area on the left 
L5 dermatome, one third the way along a line from the left lateral femoral epicondyle to the 
left lateral malleolus. Using the radial lines approach, 8 spokes were marked using a non-
permanent marker that radiated outwards from the point of capsaicin cream application. 
Mapping of altered mechanical pain sensation was performed using a 128 mN pin prick 
stimulator starting at the point of capsaicin cream application and moving outwards at 1cm 
intervals at rate of 1 stimulus/s along the length of each of the 8 spokes and a point was marked 
on each spoke at the point when the sensation changed from a sharp pinprick to a blunt 
prodding sensation. During this procedure, the participant was instructed not to observe the 





the area of skin that was reddened around the capsaicin cream application. This was evaluated 
visually and the border between the detectable erythema and normal skin pigmentation was 
marked along each of the 8 spokes (23). The areas of primary and secondary hyperalgesia were 
subsequently traced using acetate and for each area, the points on the 8 spokes were 
connected to create separate 8 sided polygons. The area of each polygon was then measured 
using an image analysis program (ImageJ, US National Institute for Health) (24).   
EPP threshold testing 
Each transcutaneous electrical stimulus consisted of a standard, constant-current 1-ms 
duration square pulse using a constant current stimulator (DS7A, Digitimer, UK) (21). For 
testing carried out in study 1, four 4.5cm points from the capsaicin application were drawn in 
proximal, distal, medial and lateral directions. Modified cathodal electrodes (Ag/AgCl; self-
adhesive, 1 cm diameter, CareFusion, UK) were used to measure EPP threshold at the point of 
capsaicin application and at each of point with an anode (Ag/AgCl ; self-adhesive, 25mm 
diameter, CareFusion, UK) placed over the patella. Pain thresholds (mA) were then determined 
using the methods of limits approach at each of the 5 points by increasing the current intensity 
in 0.5 mA steps at 1 Hz and was defined as the mean of 3 intensities logged as the point at 
which sensation transitioned from being a ‘’heavy tapping’’ sensation (i.e. no pain) to a sharp 
‘’pinprick’’ pain (21). There was a 10 second-stimulus interval between each EPP test to avoid 
sensitisation. During study 2, eight radial 4.5 cm spokes were drawn from the point of capsaicin 
application and EPP thresholds were measured across 24 points radiating outwards from the 







Heat pain threshold testing  
Heat pain thresholds were determined across the same 5 points used for EPP testing (i.e. 4 in 
a secondary zone and 1 in a primary zone) using a thermode (TSA-II, Medoc, Israel) placed over 
the skin on the leg. The baseline temperature was set to 32 °C and the temperature ramp 
increased at 1 °C/s and the participant pressed the stop button when the impression of warmth 
or heat changed towards an additional impression of burning, stinging, drilling or aching 
sensation. Heat pain thresholds were measured 3 times with a fixed inter-stimulus interval of 
10 seconds.  
Experimental protocols  
For all experiments, participants were seated on a couch with knee extended to 180°. Before 
the experiment started, each participant was familiarised with all sensory testing procedures.  
Study 1: Baseline EPP and heat pain threshold measurements were measured across 5 points; 
at the proximal, distal, medial and lateral points as well as the central capsaicin point with an 
inter-stimulus interval of 10 seconds (i.e. secondary and primary hyperalgesia zones, 
respectively; Figure 1A). Topical capsaicin cream (1% concentration; 50 µl) was then applied to 
a 9mm diameter clear plastic disc and placed faced down on the skin in the centre. VAS ratings 
were then recorded every 3 minutes to track the development of an ongoing pain state. 
Following the onset of capsaicin induced pain perception (i.e. >50 VAS rating), secondary 
mechanical hyperalgesia was mapped using a radial lines approach. EPP and heat pain 
thresholds were then re-measured at each of the proximal, distal, medial and lateral points in 
the secondary hyperalgesia zone. The capsaicin cream was then removed and EPP and heat 





Study 2: Baseline EPP thresholds were mapped across 24 points; 8 points within an inner circle 
(i.e. 1.5cm from the central point), 8 points within a middle circle (i.e. 3cm from the central 
point) and 8 points in an outer circle (i.e. 4.5cm from the central point; Figure 1C).  Participants 
were asked to attend 2 visits (separated by ~1 week) where they received topical application 
of either capsaicin cream or sham cream (Aqueous Cream B.P, Boots pharmaceuticals UK), 
which was applied to a clear plastic disc and placed faced down on the skin at the centre of the 
8 radial lines. Following the onset of capsaicin induced pain perception (i.e. when VAS ratings 
reached 50) EPP thresholds were measured in a clockwise fashion starting from the proximal 
position on the inner, middle and outer rings with an inter-stimulus interval of 10 seconds 
(Figure 1D).  
Statistical analysis  
All data were initially entered into Microsoft Excel before being analysed for normality and 
statistical significance in GraphPad Prism (GraphPad Software Inc., USA). The stability of the 
capsaicin-induced ongoing pain VAS ratings was analysed by one-way repeated measures (RM) 
ANOVA with Holm-Sidak multiple comparison post-hoc tests. Mild and severe areas of 
electrically-evoked secondary hyperalgesia were defined as the mean of the 2 smallest 
reductions in EPP threshold and the mean of the 2 greatest reductions in EPP threshold 
measured across the proximal, distal, medial and lateral points within each individual subject. 
Paired t-tests were used to analyse the difference in the capsaicin-induced reduction in EPP 
thresholds measured in the mild and severe areas in the secondary zone. The changes in HPT 
and EPP threshold measured before and after capsaicin were assessed using paired t-tests. 
During study 2, the effects of sham cream application were analysed by comparing pre- versus 





were drawn using the percentage change in EPP threshold across the 24 measurement points 
in the inner, middle and outer rings following capsaicin or sham cream application using 
SigmaPlot 12.5 (Systat Software Inc, UK). Statistical significance was set at p<0.05 and all data 
in the text are presented as mean ± SD.  
Results 
Development of capsaicin-induced ongoing pain   
Topical application of 1% capsaicin cream resulted in an initial very light tingling sensation after 
3 minutes (VAS: 0.92 ± 2.8; Figure 2). There was an overall main effect of Time (p<0.001) and 
the tingling sensation increased further until it developed into a distinct burning pain at a mean 
time of 51 minutes post-capsaicin application (i.e. VAS: 53.75 ± 14.32). Post-hoc analysis 
revealed there was no significant difference in pain rating between 51 minutes and 90 minutes 
post-capsaicin application.  
Capsaicin-induced changes in EPP threshold reveal within-subject differences in the magnitude 
of secondary hyperalgesia  
The area of flare (i.e. primary hyperalgesia zone) and punctate secondary mechanical 
hyperalgesia are shown in Table 1. Within the area of mechanical secondary hyperalgesia, 
there were differences in the degree of change in EPP threshold measured across 4 points 
covering an area of 64 cm2 within an individual subject (Figure 3A). These changes in EPP 
thresholds within the secondary zone could be categorised as the mean of the 2 smallest drop 
in threshold and mean of the 2 largest drop in threshold (i.e. mild: -4.28 ± 18.27%  versus 
severe: -21.16 ± 18.25%; p<0.001; Figure 3B). There was no change in heat pain threshold 





2.40 °C; p>0.05; Figure 3C) and severe (pre-capsaicin: 47.23 ± 1.73 °C versus post-capsaicin: 
46.60 ± 1.74 °C; Figure 3D) areas of secondary hyperalgesia.   
Changes in heat pain threshold and EPP threshold in an area of capsaicin-induced primary 
hyperalgesia  
Topical capsaicin application was associated with a robust drop in heat pain threshold in the 
area directly below the cream (pre-capsaicin: 46.59 ± 2.39 °C versus post-capsaicin: 36.04 ± 
0.84 °C; p<0.001; Figure 4A). There was also a drop in EPP threshold measured over the same 
position (pre-capsaicin: 18.34 ± 5.38 mA versus post-capsaicin: 13.95 ± 4.98 mA; p<0.001; 
Figure 4B).  
Capsaicin-induced changes in EPP threshold reveals between-subject differences in the 
magnitude of hyperalgesia  
In a separate cohort of participants, changes in EPP threshold were then mapped at 24 points 
along 8 lines radiating outwards from either real or sham capsaicin cream application. There 
was a heterogeneous response to the real capsaicin cream which could be quantified using 
subject-specific heat map analysis which show the percentage change in EPP threshold at each 
point (Figure 5). There were distinct between-subject differences in the degree of change in 
EPP threshold as well as the direction to which sensitisation to electrical stimuli spread around 
the 8 spokes.  
Sham cream application was associated with no change in mean EPP threshold measured 
across all 8 points within the inner (pre-sham: 7.7 ± 5.5 mA versus post-sham: 7.6 ± 5.3; 





sham: 7.9 ± 5.5 versus post-sham: 7.8 ± 5.4 mA; p>0.05) and there was no tingling or burning 
pain sensation reported.  
Discussion  
In this study, we have shown that measuring capsaicin-induced changes in EPP thresholds can 
provide added benefit to existing QST-based methods of assessing secondary hyperalgesia 
responses. We have demonstrated the ability of EPP to rapidly capture differences in pain 
sensitivity which could be categorised into mild and severe within an individual subject. The 
changes in EPP threshold within a secondary zone were confirmed by defining the area of 
hyperalgesia to mechanical but not heat pain stimuli. There was also a change in EPP threshold 
within an area of primary heat hyperalgesia which suggests noxious electrocutaneous 
stimulation can be used to broadly assess sensitisation across sensory nerve fiber function. We 
show that using EPP is a new approach to measuring hyperalgesic responses and allows the 
rapid determination of pain thresholds for responses across multiple electrodes. By using this 
semi-automated approach, it is possible to programme stimulation of numerous sites making 
it more efficient than manual stimulation of the same number of sites using QST based 
approaches. These results indicate that by combining electrocutaneous stimulation with 
conventional methods used to assess the surface area affected by secondary hyperalgesia, it 
is be possible to rapidly investigate within and between subject differences in both the area 
and magnitude of the secondary hyperalgesia response.  
It is recognised that there is a heterogeneous response to the induction of secondary 
hyperalgesia in healthy subjects which is typically reflected in differences in the size of the 
secondary hyperalgesia area (13). Using a burn injury model, others have previously grouped 





secondary hyperalgesia (25). In the current study we found a mean area of secondary 
mechanical hyperalgesia to be ~112 cm2 which is in line with a previous report using this 
approach (16). By doing this characterisation, we could confirm that EPP thresholds, which 
were measured within a pre-defined area of 64 cm2, were assessed within the mean secondary 
hyperalgesia zone seen using this model. However, it is important to use confirmatory QST 
assessments to determine the borders between primary and secondary hyperalgesia zones. It 
is possible that in some participants the area of secondary mechanical hyperalgesia may not 
spread evenly around the radial lines and therefore areas which are associated with no change 
in EPP threshold from baseline could in fact be measuring pain thresholds outside of the 
secondary hyperalgesia zone. Nevertheless, measuring capsaicin-induced changes in EPP 
thresholds provides the opportunity to map areas of altered pain thresholds which can be 
confirmed as either primary or secondary hyperalgesic response through QST assessments.   
We have shown that by measuring changes in EPP threshold across multiple sites within an 
area of secondary hyperalgesia it is also possible to identify areas of high and low sensitivity 
within an individual subject. This indicates different levels of heterosynaptic sensitisation of 
afferent inputs coming from 4 distinct points from the secondary hyperalgesia zone. Central 
sensitisation corresponds to an overall increase in the activity of central nociceptive pathways 
caused by increases in membrane excitability, synaptic efficacy and reduced local and 
descending inhibitory control (26). Nociceptive input from a specific receptive field is highly 
malleable and open to centrally-mediated plasticity which manifest as changes in pain 
threshold and many other features of central sensitisation (27, 28). It is therefore possible that 
dorsal horn neurons which are subject to central sensitisation may exhibit localised differences 
in the levels of sensitivity which manifest as large or small reductions in pain threshold within 





It is currently unclear why the response to secondary hyperalgesia varies despite each 
participant undergoing the same induction procedure. Results from human neuroimaging 
studies have shown that secondary hyperalgesia is associated with changes in the activation of 
brainstem regions involved in top-down inhibitory control (29-31) which has shown to be 
different based on the presence of high or low sensitisation phenotypes (25). It is therefore 
possible that changes in these spinally-projecting pathways may dictate the overall levels of 
sensitisation in the dorsal horn (12). Similar top-down inhibitory mechanisms have been 
attributed to the enhanced areas of capsaicin-induced secondary hyperalgesia seen in women 
with a history of life stressors (32). The efficiency of psychophysical measures of endogenous 
pain modulation has also been shown to vary considerably within populations of chronic pain 
patients (33-35) which may contribute to the differences seen in the severity of secondary 
hyperalgesia within the sample population of the present study. By mapping detailed changes 
in EPP threshold around an area of secondary hyperalgesia we demonstrated a spectrum of 
different severities across the participants ranging from high to low sensitivity. Future 
experiments which aim to investigate the relationship between the severity of secondary 
hyperalgesia and endogenous pain modulation may help to understand why participants fall 
into high and low sensitivity profiles. Indeed, measuring EPP thresholds alongside 
psychophysical or neuroimaging experiments may also help to improve our mechanistic 
understanding of the heterogeneity often seen in populations of chronic patients.  
Nerve block experiments have indicated a role for Aδ-fibre nociceptors in mediating the 
secondary mechanical hyperalgesia response which is thought to occur via a heterosynaptic 
facilitation in the dorsal horn (10, 14). Interestingly, we also saw changes in EPP threshold but 
no changes in heat pain threshold within the area of secondary mechanical hyperalgesia which 





sensitised Aδ-fibres. It is possible that more selectivity could be achieved by delivering a slowly 
incrementing exponential pulse through a cutaneous pin electrode, which has been shown to 
preferentially activate small diameter nerve fibres (36, 37). However, the electrocutaneous 
stimulation used in the current study was delivered using a standard patch electrode which is 
thought to activate both small and large diameter nerve fibres in an unnatural and 
synchronised manner with a bypassing of the sensory nerve endings and as such, losing the 
vital modality-specific information gained from sensory transduction (22). It is therefore 
feasible that the changes in EPP threshold seen in the primary zone could be due to activation 
of sensitised C-fibres as we all also saw concurrent changes in heat pain threshold, which is 
known to be predominantly caused as a result of C-fibre sensitisation (7, 38).  Together, this 
provides evidence that the EPP test can be used to broadly assess sensitisation across the full 
spectrum of sensory nerve fibres and may provide an efficient and cost-effective alternative to 
measuring changes in pain sensitivity in experimental and clinical pain studies assessing 
mechanisms and efficacy of analgesics.  
In conclusion, this study reveals that measuring capsaicin-induced changes in EPP thresholds 
can be used to assess changes in both primary and secondary hyperalgesia. By combining with 
QST methods used to map areas of altered mechanical sensitivity, it is possible to rapidly add 
further information on the magnitude of the secondary hyperalgesia response within an 
affected dermatome, by measuring differences in the degree of change in EPP threshold across 
numerous points using a semi-automated approach. Electrocutaneous stimulation may help to 
better understand individual differences in the magnitude of secondary hyperalgesia in human 
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Figure legends  
Figure 1. Experimental protocols. A) Measurement points used during study 1 included 4 in the 
secondary zone (proximal, medial, lateral and distal) and 1 in the primary zone. B) Baseline EPP 
and heat pain thresholds were measured in the primary and secondary zone before application 
of 1% capsaicin cream. Post-capsaicin EPP and heat pain thresholds were first measured across 
the 4 points in the secondary zone before the cream was removed and post-capsaicin 
measurements were made in the primary zone. C) Measurement points used during study 2 
included 8 within an inner ring, 8 within a middle ring and 8 within an outer ring. D) Baseline 
EPP thresholds were measured across the inner, middle and outer rings before and after 
application of either 1% capsaicin or sham cream.  For A) and C) Light grey = secondary zone, 
dark grey = primary zone, black circle = position of capsaicin application.  
Figure 2. Development of capsaicin induced ongoing pain. Time course of changes in pain 
perception following topical application of 50µl 1% capsaicin cream. The intensity of sensation 
increased until pain threshold was reached at ~51 minutes (i.e. dashed line; 50 VAS).  Data 
expressed as mean and shaded area around the curve depict the standard deviation. n = 12.   
Figure 3. Capsaicin-induced changes in EPP threshold within an area of mechanical secondary 





hyperalgesia with the percentage change in EPP thresholds measured across 4 points within 
the secondary hyperalgesia zone. B) Mild and severe areas of electrically-evoked secondary 
hyperalgesia. There was no change in heat pain thresholds measured at C) mild and D) severe 
areas of secondary hyperalgesia. Data expressed as mean with individual data points. *** - 
p<0.001; ns – not significant. n = 12.  
Figure 4. Capsaicin-induced primary hyperalgesia. There was a drop in A) heat pain threshold 
and B) EPP threshold in the area directly below the capsaicin cream application, i.e. the primary 
hyperalgesia zone. Data expressed as mean with individual data points. *** - p<0.001. n = 12. 
Figure 5. Mapping between-subject differences in the severity of hyperalgesia using EPP 
thresholds. Individual heat maps showing the percentage change in EPP threshold measured 
across 24 points along 8 spokes radiating outwards from capsaicin cream application. Red = 
greatest reduction in EPP threshold; yellow = smallest reduction in EPP threshold; green = no 
change from baseline; blue/purple = increase in EPP threshold. n = 14.  
Table 1. Mapped areas of primary and secondary hyperalgesia. The primary zone was defined 
as the border between the detectable erythema and normal skin pigmentation. The secondary 
zone was mapped by measuring changes in mechanical pain sensitivity. Data expressed as 
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Table 1.  
 
Area (cm2) ± 
SD 
 
EPP threshold (mA) 
pre-cap (range) 
EPP threshold (mA) 
post-cap (range) 
p-value 
Primary zone 6.4 ± 3.4  18.3 (7.9 – 26.7) 13.9 (5.6 – 19.8)  0.0003 
Secondary 
zone 112.6 ± 35.7 
Mild 
Severe  
17.2 (6.7 – 31.4) 
18.8 (7.2 – 29.4) 
16.5 (6.5 – 28.8) 





























Figure 5.  
 
